Description
EXERCISING OPTION YEAR ONE RADIOPHARMACEUTICAL
First action · last action
2014-10-01 · 2015-10-19
Transactions
4
First transaction's obligation
$97,993
Base + all options value (sum of deltas)
$1,405,580
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
2
SDVOSB flag on record
No
Parent IDV
VA24914D0110
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$97,993= $97,993
- Mod P000012015-04-13+$150,000= $247,993
- Mod P000022015-08-31+$12,000= $259,993
- Mod P000032015-10-19+$134= $260,127
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$97,993 | $97,993 | EXERCISING OPTION YEAR ONE RADIOPHARMACEUTICAL |
| Mod P00001· FUNDING ONLY ACTION | 2015-04-13 | +$150,000 | $247,993 | EXERCISING OPTION YEAR ONE RADIOPHARMACEUTICAL |
| Mod P00002· FUNDING ONLY ACTION | 2015-08-31 | +$12,000 | $259,993 | EXERCISING OPTION YEAR ONE RADIOPHARMACEUTICAL |
| Mod P00003· FUNDING ONLY ACTION | 2015-10-19 | +$134 | $260,127 | EXERCISING OPTION YEAR ONE RADIOPHARMACEUTICAL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZTPJLM54CAN3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24919N0063 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $102,389 | FY2019 |
| VA24918J2822 | 626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS | $434,829 | FY2018 |
| VA24917J2761 | 626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS | $411,685 | FY2017 |
| VA24916J3572 | 626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS | $283,942 | FY2016 |
| VA24914J1511 | 626-NASHVILLE · 6505 · DRUGS AND BIOLOGICALS | $116,003 | FY2014 |
| VA24914D0110 | 626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2014 |
Other recipients under 6505 from 626-NASHVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24916J2025 | EISAI INC. | 626-NASHVILLE | $10,442 | FY2016 |
| VA24916J2023 | EISAI INC. | 626-NASHVILLE | $9,357 | FY2016 |
| VA24916J2003 | LUNDBECK LLC | 626-NASHVILLE | $6,255 | FY2016 |
| VA24916F1754 | GRIFOLS THERAPEUTICS LLC | 626-NASHVILLE | $9,974 | FY2016 |
| VA24916J1738 | CSL BEHRING L.L.C. | 626-NASHVILLE | $73,561 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24915J3595_3600_VA24914D0110_3600 · retrieved 2026-09-26.